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In 824 patients who underwent directional vacuumassisted biopsies (DVABs) of breast microcalcifications, 61 (7.4%) showed atypical ductal hyperplasia (ADH). The 42 who subsequently underwent excision were the subjects of this study. Cases were evaluated for the mammographic characteristics of the lesion, the percentage of lesion removed according to mammography, and histologic findings (including number of large ducts and/or terminal duct-lobular units involved with ADH) in DVAB specimens. Pathologic findings in the surgical specimens in the area of the biopsy site also were recorded. In the DVAB specimens, ADH was confined to an average of 1.5 large ducts or lobular units and was associated with microcalcifications in all of the patients. Surgical specimens showed ADH in 15 cases, no residual lesion in 24 cases, and ductal carcinoma in situ in 3 cases. We found that microcalcifications that contain ADH in less than 3 lobules or ducts and/or that are removed completely by DVAB do not reveal higher-risk lesions on excision; thus, removal is unnecessary. When assessing microcalcifications with ADH, clinicians should consider the percentage of microcalcifications removed by DVAB and the extent of lobular involvement to better assess the need for excision.
Percutaneous image-guided core needle breast biopsy is used commonly to diagnose breast lesions. Early experiences with a 14-gauge automated biopsy core needle showed that this technique's diagnostic accuracy was comparable to that of surgical excision after wire localization. [1] [2] [3] [4] Particular advantages of percutaneous core biopsy are that it can obviate the need for surgery in women with benign lesions [5] [6] [7] [8] and can reduce the number of surgical procedures performed in women with breast cancer. [5] [6] [7] [9] [10] [11] A limitation of the core needle biopsy, however, is that it potentially underestimates ductal carcinoma in situ (DCIS) or invasive ductal carcinoma (IDC) lesions. [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] Atypical ductal hyperplasia (ADH) is a proliferative breast lesion diagnosed on the basis of the following histologic findings: (1) cytologic features of low-grade DCIS present in the hyperplasia but the overall architecture is that of intraductal hyperplasia or (2) both cytologic and architectural features of low-grade DCIS present in 1 or more ducts but the ducts do not exceed 2 mm in aggregate diameter. 23, 24 Because the distinction between DCIS and ADH is quantitative, it is not possible to make a definitive diagnosis of DCIS on the basis of limited biopsy material showing less than 2 mm of the lesion on the glass slide; rather, ADH is diagnosed instead. In breast lesions surgically excised after a histopathologic diagnosis of ADH based on findings from a 14-gauge stereotactically guided automated core biopsy, the prevalence of carcinoma has ranged from 11% to 68%. [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] Thus, a lesion diagnosed as ADH on the basis of core needle biopsy findings would need to be excised to rule out carcinoma.
A newer percutaneous needle biopsy technique, the directional, vacuum-assisted biopsy (DVAB) technique (using an 11-or 14-gauge needle) is being used increasingly in place of the automated needle. The DVAB has several design advantages over the automated needle; DVAB can (1) extract more contiguous tissue than an automated largecore biopsy needle; (2) acquire tissue farther from the probe, not just within the line of fire; and (3) obtain multiple specimens from a single insertion of the probe. 16, 25, 26 Because individual specimens are larger and multiple specimens are easier to obtain, a much larger volume of tissue can be obtained with DVAB than with an automated core biopsy needle; as a result, ADH or DCIS might be more accurately characterized. The reported rate of ADH underestimation of DCIS and invasive breast cancer in studies using DVAB ranges from 0% to 38%. [15] [16] [17] [18] [19] [20] [27] [28] [29] [30] Despite this improvement, however, the prevalence of carcinoma in these lesions is still sufficiently high to warrant surgical excision if ADH is found.
A few studies have attempted to determine predictors of ADH underestimation in core needle biopsy specimens. 16, 27, 31, 32 For example, Ely and coworkers 31 described a series of 47 patients in whom core needle biopsy specimens (DVAB) containing ADH in less than 3 lobular units consistently correlated with a surgical specimen free of a higher-risk (DCIS or invasive cancer) lesion. In addition, others have found that the greater the proportion of the lesion removed at the time of biopsy, the less likely is underestimation. 16, 27, 32 We undertook this retrospective study of microcalcifications with ADH in DVAB specimens to determine whether we could identify features that predict which lesions should be excised and which are unlikely to contain higher-risk disease.
Materials and Methods
From April 1997 to December 2001, stereotactically guided DVAB of microcalcifications was performed on 824 patients at the University of Texas M.D. Anderson Cancer Center, Houston. ADH was found in the specimens of 61 women (7.4%). Of these women, 42 subsequently underwent excision, and they were the subjects of this study. The remaining patients were undergoing therapy for advanced malignancy of other sites, and, therefore, their breast lesions were followed up clinically by mammography.
For the biopsy procedure, the patient was positioned prone on the stereotactic unit (US Surgical Corporation ABBI system, Lorad, Danbury, CT). Digital scout images were obtained, and target coordinates were confirmed. The skin of the breast was cleaned in an aseptic manner. Thereafter, 1% lidocaine with epinephrine mixed with sodium bicarbonate was administered for local anesthesia. A short skin incision was made with a scalpel. The lesion was targeted, and the DVAB device (Mammotome, Biopsys/Ethicon EndoSurgery, Cincinnati, OH) was advanced to the appropriate depth. Prebiopsy and postbiopsy images were obtained. A single needle insertion was performed, and an average of 10.8 cores (range, 6-22 cores) per lesion were obtained using an 11-or 14-gauge biopsy device.
Core samples were placed on a Telfa pad (Kendall, Milford, OH) in a Petri dish and kept moist with a drop of sterile saline on the pad. After magnification specimen radiography, the cores containing calcifications were marked with India ink before fixation (in 10% neutral buffered formalin solution) so that the microcalcifications could be identified easily for pathologic correlation. Six tissue sections were obtained per tissue block, but only the first and last levels were stained with H&E for histologic evaluation (unstained slides were reserved for marker studies or additional stains, if needed). Tissue microcalcifications were correlated with those shown on specimen radiographs to determine whether microcalcifications were well represented on the slides. Tissue was obtained at deeper levels if cases were thought to be sectioned inadequately.
Specimen radiographs for the needle-localized surgical excision are routinely assessed intraoperatively and compared with preoperative mammograms by the radiologist and the pathologist to determine accurate excision. Tissue samples containing microcalcifications, as well as tissue samples from additional abnormalities detected by gross histopathologic evaluation or specimen radiography, are submitted for histologic evaluation.
In all of the cases, the core biopsy and subsequent excision specimens were evaluated by a dedicated breast pathologist (N.S.). ADH was identified on the basis of the criteria described by Page et al 24 and Tavassoli. 23 Additional findings also were recorded, such as the presence of columnar cell alteration with apical snouts and secretions (CAPSS) with or without atypia. The location of microcalcifications, whether in the ADH area, the CAPSS area, the vascular wall, or other components, also was noted. The extent of ADH on DVAB was determined on the basis of the criteria described by Ely et al. 31 ADH restricted to 1 large duct or 1 terminal duct-lobular unit represented a single focus; involvement of 1 duct and 1 terminal duct-lobular unit represented 2 foci; and so on.
Mammograms obtained before and following the DVAB procedure and specimen radiographs were reviewed retrospectively by a breast imager (G.J.W.) to determine lesion characteristics (calcifications with or without associated architectural distortion or mass) and the proportion of calcifications removed per lesion during DVAB. The targeted lesions were measured in 3 dimensions on the diagnostic mammograms. The prebiopsy diagnostic mammograms were compared with the postbiopsy mammograms to determine the percentage of the lesion that was removed. Morphologic features of the calcification were classified according to the American College of Radiology Breast Imaging Reporting and Data System (BI-RADS) lexicon. 33 The mammographic findings at the time of needle localization for surgical excision were assessed by both the radiologist and the pathologist. ADH was defined as being diagnosed accurately when the histologic diagnosis made on the basis of the excisional biopsy findings was the same as or at a lower stage than the diagnosis based on the DVAB findings; this included the finding of no residual ADH at surgery. ADH was defined as underestimated when a lesion that yielded the histologic diagnosis of ADH on stereotactic biopsy showed DCIS or invasive cancer at surgery.
For statistical analysis, the Cochran-Armitage test for trend was used to study the association of DCIS and IDC outcome with the number of ADH foci on DVAB. P values of less than .05 were considered statistically significant.
Results
The 42 patients ranged in age from 38 to 76 years (mean, 56 years). Needle biopsy was performed in all cases to sample nonpalpable, mammographically detected microcalcifications. In 1 patient, microcalcifications were associated with an asymmetric density. In the remaining 41 patients, microcalcifications were not associated with a mass or any other lesions. The size of the calcification areas seen on the mammograms ranged from 0.3 to 8.5 cm (mean, 1.6 cm). The calcification pattern was classified as amorphous in 18 lesions, pleomorphic in 11, granular in 6, punctate in 2, and indeterminate in 4. All groups of calcifications but 1, which was classified as BI-RADS category 5, were categorized as BI-RADS category 4 lesions. A mean of 10.8 core samples (range, 6-22 core samples) was obtained from each lesion ❚Table 1❚. Cores with calcifications were confirmed in all cases, with an average of 5 cores (range, 2-11 cores) containing calcifications in each case.
Microscopically, the extent of ADH on DVAB was limited to 1 focus (lobule or duct) in 21 cases (50%), 2 foci in 7 cases (17%), 3 foci in 5 cases (12%), and 4 or more foci in 9 cases (21%). Associated calcifications were noted in all foci of ADH ❚Image 1❚. Additional pathologic findings included a background of CAPSS in all cases, with associated cytologic atypia in 25 (60%) and lobular neoplasia in 6 (14%) of the cases. Calcifications also were noted within CAPSS and some nonproliferative breast lobules.
The excised surgical specimens from the 42 patients showed no higher-risk lesions in 39 patients (93%) and DCIS in 3 patients (1 with associated invasion), for an ADH underestimation rate of 7%. Microscopic evidence of the previous DVAB also was demonstrated in all cases.
❚Table 2❚ summarizes the extent of ADH lesions shown by DVAB and the corresponding findings in the excised specimens. The number of lobules or ducts with ADH was associated significantly with excision findings (P = .02). Specifically, ADH involving 3 or more lobules or ducts was associated with a higher-risk lesion. ❚Table 3❚ summarizes the relationship of the number of cores, cores with calcifications, the percentages of calcifications removed, and the findings in the excised surgical specimens. In the 39 patients who proved to have no higher-risk lesions on excision, the maximum extent of the microcalcifications ranged from 0.3 to 8.5 cm (mean, 1.6 cm), with DVAB resulting in removal of 5% to 100% (mean, 70%) of the lesions. In 24 (62%) of 39 cases of ADH, no residual lesions were found on excision, and in 14 (58%) of these, the lesion measured less than 1.0 cm. In the 3 DCIS/IDC cases, microcalcifications extended for a maximum length of 1.5, 4.0, and 7.0 cm, and approximately 70%, 20%, and 15% of the calcifications were removed by DVAB, respectively. The limited number of cases of DCIS/IDC does not permit meaningful statistical analysis. However, in comparison with the remaining cases, in which no higher-risk lesions were found, the lesions in the DCIS/IDC cases tended to be larger, and a lower percentage of the lesion was removed. The 1 BI-RADS category 5 lesion showed extensive DCIS on surgical excision.
Discussion
In our study, the overall rate with which DCIS and IDC were underestimated was 7% (3/42), which is among the lowest reported for DVAB. In previous reports, ADH underestimation of DCIS and invasive cancer has ranged from 0% to 38%, [15] [16] [17] [18] [19] [20] [27] [28] [29] [30] 32 and, as a result, surgical excision of cases diagnosed as ADH has been suggested. A summary of all DVAB series as reported in the literature is given in ❚Table 4❚.
Predictors of ADH underestimation for DCIS and IDC have been the subject of a few studies. In a few series, the authors found that the greater the proportion of microcalcifications removed, the less likely was underestimation. 16, 27, 32 In another study, histologic features regarding the extent and pattern of ADH on core biopsy specimens were found to predict tissue findings at excision. 31 In that study, ADH confined to 2 or fewer lobular units consistently correlated with surgical findings free of a higher-risk lesion; a pure micropapillary ADH pattern was indicative of extensive disease. In our series, none of the patients with 1 or 2 foci of ADH on DVAB analysis were found to have DCIS or invasive cancer at surgery. In contrast, in the 3 cases with DCIS/IDC underestimation, the average number of lobules containing ADH on DVAB was higher (3 or more) than that noted for patients with no DCIS or IDC found on excision. This finding is similar to that reported by Ely et al. 31 Evaluation of the size of abnormality, percentages of calcification sampled, the number of core samples, and the histologic pattern of ADH lesions in relation to surgical excision findings was limited because of the small number of DCIS and IDC cases. When no residual ADH is identified histologically after a DVAB in an adequately localized specimen, the lesion is considered to have been completely excised at the time of DVAB. Overall, 54% (22/41) of the lesions with microcalcifications in the present study were removed entirely, and most of these measured less than 1.0 cm in the greatest extent. In Burbank's 15 experience, 93% of 1-to 5-mm lesions as opposed to 56% of the 6-to 10-mm lesions were removed completely using DVAB. Most important, however, none of our cases in which microcalcifications were removed completely revealed a higher-risk lesion in the excised specimen. Similar findings were reported by Liberman et al, 16 Philpotts et al, 27 and Renshaw et al. 32 In their studies, no ADH underestimation occurred in the cases in which all calcifications were removed.
Although a certain number of tissue cores is recommended for accurate lesion categorization, the underestimation rate is not related to the number of cores obtained. 13, 17, 18, 27, 28 This might be explained by the fact that the number of cores obtained may not accurately reflect how thoroughly the lesion is sampled with DVAB. In this series, because of the small number of DCIS and IDC cases (n = 3), no correlation could be made between the number of core samples obtained and the underdiagnosis of carcinoma.
The 11-gauge DVAB device harvests larger tissue cores than the 14-gauge DVAB, and, therefore, its use may reduce the discordance between ADH found on core biopsy specimens and carcinoma found in excised tissue. 15, 28, 29 In most of our cases, including the case in which ADH was underestimated, the specimens were removed using an 11-gauge DVAB device. In this series, the diagnostic accuracy of the 11-gauge probe could not be compared with that of the 14-gauge needle because of the limited number of cases (n = 3) in which the 14-gauge probe was used.
Our findings show that the number of lobules or ducts with ADH in DVAB samples is associated significantly with findings on surgical excision. Microcalcifications sampled by DVAB that show ADH confined to less than 3 ducts or lobular units may rule out a higher-risk lesion requiring surgical excision. Similarly, if microcalcifications that have been removed completely by DVAB show ADH, the lesion may be considered to have been adequately represented with no risk of ADH underestimation. Therefore, when assessing microcalcifications with ADH, we suggest that information about the percentage of microcalcifications removed by DVAB and the extent of lobular involvement seen during microscopic examination be considered in the selection of patients for surgical excision. Prospective studies are needed for further validation of these findings. ADH, atypical ductal hyperplasia; DVAB, directional vacuum-assisted stereotactic biopsy; NA, not available. * Some reports provided only the mean lesion size or the mean number of cores. All series except Darling et al 28 and the present study included a few mass lesions in addition to microcalcifications.
